M14-431
ClinicalTrials.gov NCT03345823
Research payments
$5,101,202
Through program year 2020, $5,101,202 in research payments was reported against M14-431, across 803 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03345823
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $1,463,461 | 287 |
| 2019 | Research | $3,637,742 | 516 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Esther Torres San Juan, PR Named on 33 payments
- Edward Loftus Rochester, MN Named on 33 payments
- Jonathan Siegel Mobile, AL Named on 30 payments
- Joe Pouzar Houston, TX Named on 26 payments
- Sara Horst Nashville, TN Named on 25 payments
- Harvey Tatum Tulsa, OK Named on 22 payments
- Suzy Kim Greenville, SC Named on 18 payments
- Jason Hou Houston, TX Named on 16 payments
- Philip Ginsburg Hamden, CT Named on 16 payments
- Henry Levine Orlando, FL Named on 16 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.